Published in
Iranian Red Crescent Medical Journal, Iranian Red Crescent Medical Journal, 5(16), 2014
DOI: 10.5812/ircmj.11284
Links
- ORCID
- Iranian Red Crescent Medical Journal
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation
Journal article published in 2014 by
Hormoz Ayromlou,
Hassan Soleimanpour,
Mehdi Farhoudi,
Aliakbar Taheraghdam,
Elyar Sadeghi Hokmabadi,
Elyar Sadeghi Hokmabadi 
,
Rouzbeh Rajaei Ghafouri,
Rouzbeh Rajaei Ghafouri,
Mehdi Najafi Nashali,
Ehsan Sharifipour,
Somayeh Mostafaei,
Davar Altafi
,
Rouzbeh Rajaei Ghafouri,
Rouzbeh Rajaei Ghafouri,
Mehdi Najafi Nashali,
Ehsan Sharifipour,
Somayeh Mostafaei,
Davar Altafi
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Intravenous thrombolysis is an approved treatment method for patients with acute ischemic stroke (AIS) and is recommended by multiple guidelines. However, it seems that it is less frequently used in the developing countries compared to the developed countries.